COVID-19 oral treatment (Paxlovid)

Paxlovid is the first specific oral treatment for COVID-19. It comes in tablet form.

Although Paxlovid does not prevent COVID-19 or replace vaccination against COVID-19, it is intended to reduce the severity of COVID-19 symptoms in people at risk of developing serious complications from this infection. It is estimated to reduce the risk of hospitalization or death from COVID-19.

Eligibility criteria and details

To find out if you are eligible to receive Paxlovid, please consult the following links:

 

Consumer information on Paxlovid is available on the Government of Canada’s website.

Get Started

By continuing, you consent to sharing personal information with Pharmacie Raji Al-Kurdi Inc, Affliated with Mednow

Disclaimer

Consultation services are provided at no cost to the patient. Either the consultation is free of charge (consultations outside of RAMQ coverage), or it is fully covered by RAMQ or your private insurer upon presentation of your coverage information.

The medications and pharmaceutical services featured are provided exclusively by the pharmacists at Pharmacie Raji Al-Kurdi Inc affiliated with Mednow. In providing related services, they are acting exclusively on behalf of Pharmacie Raji Al-Kurdi Inc. Certain conditions may apply; Speak to your pharmacist.